Page 3 - Generation Ventures News Today

All the latest martech and adtech news from Freshworks, NielsenIQ, Optimove, Bigeye, ActionIQ, Blackbird.AI, Litmus and Talkwalker

Blue J, the leading provider of predictive analysis tools for tax positions, today announces that the company has raised US$9M in Series B financing led by Generation Ventures.

Algolux, a Montreal, QC, Canada-based computer vision software company, raised $18.4M in Series B funding. The round was led by Forte Ventures and Drive Capital with participation from Investissement Quebec, Castor Ventures, Nikon-SBI Innovation Fund, GM Ventures, Generation Ventures and Intact Ventures. As part of the funding round, Louis Rajczi, Partner at Forte Ventures, and Alistair Mitchell, President at Generation Ventures have joined the Algolux Board of Directors. Alan MacIntosh, Boa...

Sponsored Links Algolux, an AI software company based out of Quebec, has announced the closure of series B funding, raising $18.4 million to help accelerate market adoption of the company’s scalable computer vision and image optimization solutions. GM Ventures was among the companies leading this investment round. The other companies leading the series B funding round included Forte Ventures, Drive Capital, Investissement Quebec, Castor Ventures, Nikon-SBI Innovation Fund, Generation Ventures...

Share this article Share this article SAN DIEGO, April 29, 2021 /PRNewswire/ -- i2020, an accelerator program backed by the San Diego-based venture company Torrey Pines Investment, has announced multiple start-up and follow-on investment rounds together with OrbiMed and a start-up investment in a European science-based venture, together with OrbiMed and BioGeneration Ventures (BGV). The proceeds of the follow-ons will be used to further support the three previously funded, oncology-focused comp...

Share: BGV now one of the largest biotech investors in early stage ventures and company creation in Europe BGV IV includes new investors Eli Lilly and Company and Novo Holdings, joining existing investors Bristol Myers Squibb, European Investment Fund, Industriens Pension, KfW Capital, Schroder Adveq Four investments already made from BGV IV, with focus on entrepreneurial, therapeutic innovation BioGeneration Ventures (BGV), a leading early-stage VC in European biopharma, announces the closing...

Share: COPENHAGEN, Denmark, Jan. 7, 2021 /PRNewswire/ -- Novo Ventures, the ventures arm of Novo Holdings, today announces its participation in the BioGeneration Ventures (BGV) oversubscribed fourth fund, BGV IV, which has closed at EUR 140M ($170 million).  As one of the most active biotech investors in US and Europe, Novo Ventures investment strategy is to identify and invest in life science companies developing innovative products with the potential to significantly advance patient care. ...